According to Immix Biopharma's latest financial reports the company's current earnings (TTM) are -$19.78 M. In 2023 the company made an earning of -$15.73 M a decrease over its 2022 earnings that were of -$8.22 M.The earnings displayed on this page is the company's Pretax Income.